These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11343382)

  • 1. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.
    Gurgey A; Haznedaroglu IC; Egesel T; Buyukasik Y; Ozcebe OI; Sayinalp N; Dundar SV; Bayraktar Y
    Am J Hematol; 2001 Jun; 67(2):107-11. PubMed ID: 11343382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.
    Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E
    Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
    Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T.
    Gurgey A; Unal S; Okur H; Duru F; Gumruk F
    Pediatr Hematol Oncol; 2005 Jun; 22(4):309-14. PubMed ID: 16020118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies.
    Sucker C; Kurschat C; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Ostojic L; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2009; 15(3):360-3. PubMed ID: 19448164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
    Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
    Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of factor V Leiden and prothrombin G20210A gene mutation.
    Irdem A; Devecioglu C; Batun S; Soker M; Sucakli IA
    Saudi Med J; 2005 Apr; 26(4):580-3. PubMed ID: 15900364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
    Ozmen F; Ozmen MM; Ozalp N; Akar N
    Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction.
    Schlembach D; Beinder E; Zingsem J; Wunsiedler U; Beckmann MW; Fischer T
    Clin Sci (Lond); 2003 Sep; 105(3):279-85. PubMed ID: 12725641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
    Törüner M; Erkan O; Soykan I; Bozdayi M; Cetinkaya H; Yurdaydin C; Uzunalimoğlu O; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):250-2. PubMed ID: 16249980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.